Literature DB >> 699676

In vitro antibiotic sensitivity of Moraxella species.

S L Rosenthal, L F Freundlich, G L Gilardi, F Y Clodomar.   

Abstract

Minimal inhibitory concentrations of 17 antibacterial agents for 34 Moraxella strains were determined using a plate dilution method. A strain of Moraxella nonliquefaciens was found which produced beta-lactamase and was resistant to ampicillin and carbenicillin but not to cephalothin. Several strains were relatively resistant to erythromycin and sulfisoxazole. Disk sensitivity tests could be used to reliably predict penicillin and erythromycin resistance but not sulfisoxazole resistance.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699676     DOI: 10.1159/000237808

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

1.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

2.  Three cases of Moraxella osloensis meningitis: a difficult experience in species identification and determination of clinical significance.

Authors:  Kyoung Ho Roh; Chang Ki Kim; Eunmi Koh; Myung Sook Kim; Dongeun Yong; Soo Chul Park; Kyungwon Lee; Yunsop Chong
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

3.  Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.

Authors:  I Eliasson; C Kamme; M Vang; S G Waley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

4.  Beta-lactamase production in the upper respiratory tract flora.

Authors:  I Eliasson; C Kamme; K Prellner
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

5.  Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.

Authors:  I Eliasson; C Kamme
Journal:  Drugs       Date:  1986       Impact factor: 9.546

6.  The first Korean case of Moraxella osloensis bacteremia in a patient with acute myeloid leukemia.

Authors:  Ji Yeon Sung; Sung Kuk Hong; Eui-Chong Kim
Journal:  Ann Lab Med       Date:  2014-04-08       Impact factor: 3.464

7.  Moraxella osloensis: an unusual cause of central venous catheter infection in a cancer patient.

Authors:  Yoshiro Hadano; Kenta Ito; Jun Suzuki; Ichiro Kawamura; Hanako Kurai; Kiyofumi Ohkusu
Journal:  Int J Gen Med       Date:  2012-10-17

8.  An unusual osteomyelitis caused by Moraxella osloensis: A case report.

Authors:  Nidal J Alkhatib; Manaf H Younis; Ahmad S Alobaidi; Nebal M Shaath
Journal:  Int J Surg Case Rep       Date:  2017-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.